Prostate Cancer Research
PCF empowers the world’s top scientific minds by cutting red tape and encouraging collaboration to speed breakthroughs. Learn more about our unique funding strategies and important discoveries.
Research
Accomplishments
Advances in clinical research, treatment strategies, and basic science funded by PCF.
Funding Strategy
PCF awards programs support novel ideas, collaborative teams, and promising long-term projects.
Research News
New developments in prostate cancer research
- 8/26/2010 Initial Savings May Hide True Cost of Prostate Cancer Care | Some treatments might be less costly short term, but more expensive over time, study finds
- 8/19/2010 Testing of Brothers May Boost Family's Prostate Cancer Rates | Increased diagnostic activity may lead to siblings finding more early stage disease
- 8/12/2010 Docs Shying Away From Drug That May Prevent Prostate Cancer | Erroneous fear that finasteride spurs more aggressive tumors has left some physicians wary
- 8/6/2010 Statins, Painkillers May Upset PSA Test Results | Common medications might affect prostate cancer diagnoses, researchers say
- 7/29/2010 Scientists at UCLA Identify for the First Time a Cell-of-Origin for Human Prostate Cancer | Discovery could result in better predictive and diagnostics tools and the development of new treatments
- 7/26/2010 Most Men With Low-Risk Prostate Cancer Treated Aggressively | Many would do just as well with watchful waiting, researchers say
- 7/23/2010 Consumer Gene Test Results Misleading | At home saliva genetic tests show inconsistent results
- 7/21/2010 No Link Seen Between Coffee, Prostate Cancer Risk | New research shows no added risk for coffee drinkers
Other Research News
News especially for the researcher community
- Current and Future Applications of MR-guided Focused Ultrasound, 2010 Symposium | Deadline for abstracts: August 16, 2010
PCCTC Consortium
The DoD and PCF-funded Prostate Cancer Clinical Trials Consortium fosters collaboration across leading cancer centers and scientists.
Stay Informed
Sign up to receive our monthly newsletters.
DR. GERHARDT ATTARD ON ABIRATERONE
PCF-funded researcher discusses Abiraterone, a drug currently in trials for use in advanced prostate cancer. Watch this.